Jazz Pharmaceuticals (JAZZ) Cutting PT on Higher OpEx - Mizuho

August 10, 2016 6:19 AM

Mizuho Securities analyst, Irena Koffler, reiterated her Buy rating on shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) but reduced her ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found